PubRank

Leanna J Standish

Author PubWeight™ 26.46‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Changes in diet, physical activity, and supplement use among adults diagnosed with cancer. J Am Diet Assoc 2003 2.11
2 Types of alternative medicine used by patients with breast, colon, or prostate cancer: predictors, motives, and costs. J Altern Complement Med 2002 1.85
3 Algorithm for complementary and alternative medicine practice and research in type 2 diabetes. J Altern Complement Med 2007 1.64
4 Echinacea purpurea for prevention of upper respiratory tract infections in children. J Altern Complement Med 2005 1.40
5 Polysaccharide krestin is a novel TLR2 agonist that mediates inhibition of tumor growth via stimulation of CD8 T cells and NK cells. Clin Cancer Res 2010 1.20
6 The use of complementary and alternative medical providers by insured cancer patients in Washington State. Cancer 2004 1.14
7 Quality of life at the end of life. Health Qual Life Outcomes 2007 1.14
8 Sex differences in motives for use of complementary and alternative medicine among cancer patients. Altern Ther Health Med 2004 1.09
9 Phase 1 Clinical Trial of Trametes versicolor in Women with Breast Cancer. ISRN Oncol 2012 1.08
10 Description of clinical risk factor changes during naturopathic care for type 2 diabetes. J Altern Complement Med 2009 1.08
11 TLR2 agonist PSK activates human NK cells and enhances the antitumor effect of HER2-targeted monoclonal antibody therapy. Clin Cancer Res 2011 1.00
12 Use of complementary and alternative medicine (CAM) by Washington State hospices. Am J Hosp Palliat Care 2008 0.96
13 Dangerous combinations: Ingestible CAM supplement use during chemotherapy in patients with ovarian cancer. J Altern Complement Med 2013 0.96
14 Might massage or guided meditation provide "means to a better end"? Primary outcomes from an efficacy trial with patients at the end of life. J Palliat Care 2009 0.95
15 Silybin treatment is associated with reduction in serum ferritin in patients with chronic hepatitis C. J Clin Gastroenterol 2008 0.92
16 Evaluating CAM treatment at the end of life: a review of clinical trials for massage and meditation. Complement Ther Med 2006 0.92
17 Survival in HIV-1-positve adults practicing psychological or spiritual activities for one year. Altern Ther Health Med 2007 0.91
18 MRI evaluation of metal acupuncture needles. Acupunct Med 2013 0.86
19 Evidence for correlations between distant intentionality and brain function in recipients: a functional magnetic resonance imaging analysis. J Altern Complement Med 2005 0.84
20 Replicable functional magnetic resonance imaging evidence of correlated brain signals between physically and sensory isolated subjects. J Altern Complement Med 2005 0.84
21 Involvement in decision-making about treatment and ovarian cancer survivor quality of life. Gynecol Oncol 2011 0.81
22 Direct analysis of psychoactive tryptamine and harmala alkaloids in the Amazonian botanical medicine ayahuasca by liquid chromatography-electrospray ionization-tandem mass spectrometry. J Chromatogr A 2009 0.78
23 Low Doses of Traditional Nanophytomedicines for Clinical Treatment: Manufacturing Processes and Nonlinear Response Patterns. J Nanosci Nanotechnol 2015 0.76
24 No matter how well done, [corrected] HIV/AIDS CAM utilization papers in 2006 make us sad. J Altern Complement Med 2006 0.75
25 Adverse events associated with complementary and alternative medicine use in ovarian cancer patients. Integr Cancer Ther 2013 0.75
26 Three lessons from a randomized trial of massage and meditation at end of life: patient benefit, outcome measure selection, and design of trials with terminally ill patients. Am J Hosp Palliat Care 2009 0.75
27 A survey of complementary and alternative medicine (CAM) awareness among neurosurgeons in Washington State. J Altern Complement Med 2009 0.75